Long-term Cardiovascular Impact of COVID-19: A Review of 71 Studies

A review summarizing evidence from 71 studies published between December 2019 and January 2024 on the long-term cardiovascular impact of COVID-19. The dataset, created by Nutan Maurya and shared under a CC-BY-4.0 license, focuses on differences between hospitalised and non-hospitalised patients. It includes a narrative synthesis of observational studies, primarily from Europe and Asia, with follow-up periods ranging from less than one to over 24 months.

Use Cases

• Summarizing long-term cardiovascular outcomes of COVID-19 based on the review of 71 studies.
• Comparing cardiovascular risk between hospitalised and non-hospitalised patients based on the described findings.
• Identifying common cardiovascular manifestations like palpitations and chest pain based on the reported results.
• Analyzing the potential protective effect of vaccination against long-term cardiac complications based on the review's conclusion.

Strengths

• Includes 71 studies, providing a broad evidence base.
• Covers a defined time range from December 2019 to January 2024.
• Explicitly compares hospitalised and non-hospitalised patient groups as described.

Limitations

• The dataset is a 91.3 KB ZIP file, indicating a very limited scope, likely containing only the review document.
• Row count and column-level data are unknown; the content is a synthesized review rather than primary observational data.
• Description metadata is limited; actual data quality requires manual inspection after download.

Provenance

Source

figshare

Collection Method

Narrative synthesis review of studies from PubMed, MEDLINE, CINAHL, and Embase.

Time Range

Studies published between December 2019 and January 2024.

Freshness

Last updated 2026-05-07 05:42:57; freshness should be verified.

Geography

Studies were primarily conducted in Europe and Asia.